Vizz being approved by the FDA marks a step in the right direction for treating vision loss in an accessible way.

Lenz Therapeutics has received approval from the Food and Drug Administration for Vizz (aceclidine ophthalmic solution) 1.44% ...

It is anticipated that Vizz, manufactured by Lenz Therapeutics, will become commercially available in the US by the end of ...

The US Food and Drug Administration has approved the first eye drop that can fix near vision, promising to help ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults ...

The US Food and Drug Administration has approved Vizz eye drops. These drops improve near vision for adults over 40. Lenz ...

Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

Our data shows VIZZ (aceclidine 1.44%) received FDA approval in July 2025, positioning the once-daily, preservative-free ...

See the latest LENZ Therapeutics Inc stock price (LENZ:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

FDA approves Vizz eye drops to improve near vision in adults The U.S. Food and Drug Administration has approved Vizz 1.44% (aceclidine ophthalmic solution) for the treatment of presbyopia in adults.